Brain Cancer

Latest News

Brain cancer
Vorasidenib Garners PFS Improvement For Patients With IDH1/2-Mutant Low-Grade Glioma

March 19th 2023

Vorasidenib met its prespecified progression-free survival endpoint in the phase 3 INDIGO trial.

Chemoimmunotherapy Yields Promising Objective Responses in Patients With High-Risk Neuroblastoma
Chemoimmunotherapy Yields Promising Objective Responses in Patients With High-Risk Neuroblastoma

November 3rd 2022

Reirradiation May Play a Role in Recurrent Glioblastoma, Although Optimal Treatment Remains Controversial
Reirradiation May Play a Role in Recurrent Glioblastoma, Although Optimal Treatment Remains Controversial

October 26th 2022

Nurse Leaders Must Foster Change to Develop a Healthy Workplace Environment
Nurse Leaders Must Foster Change to Develop a Healthy Workplace Environment

October 20th 2022

Advanced Practice Providers Are Uniquely Suited for Survivorship Care
Advanced Practice Providers Are Uniquely Suited for Survivorship Care

October 13th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.